BioSpace News Archive

Drug Development

Bicycle Therapeutics Announces Clinical Milestone & Expands Collaboration with ThromboGenics

Phase 1 clinical study initiated evaluating THR-149 in diabetic macular edema (DME) Alliance extended to develop additional Bicycles for ophthalmology

May 25, 2018
·
4 min read
Business

MedAmerica Properties Inc. Appoints Real Estate Veteran Vineet Bedi, CFA to the Board of Directors

MedAmerica Properties Inc. (OTC: MAMP) (“MedAmerica” or the “Company”) today announced that Vineet Bedi, CFA has been appointed to the Board of Directors, effective May 23, 2018.

May 25, 2018
·
4 min read
Indivior Announces Regulatory Submission to Australia’s Therapeutic Goods Administration (TGA) for SUBLOCADE™ (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence

Indivior PLC (LON: INDV) today announced that it has filed a regulatory submission with Australia’s Therapeutic Goods Administration (TGA) for SUBLOCADE™ (buprenorphine extended-release) injection, for subcutaneous use, for the treatment of opioid dependence within a framework of medical, social and psychological treatment. If approved, SUBLOCADE will be marketed by Indivior Pty Ltd in Australia.

May 25, 2018
·
6 min read
Pharm Country

BrainStorm Cell Therapeutics Issues Statement on “Right to Try” Legislation

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today issues a statement following Congress passing the Federal “Right-to-Try” bill.

May 25, 2018
·
5 min read
Pharm Country

Glenmark Pharmaceuticals Announces Poster Presentations on GBR 1302 and GBR 1342, HER2xCD3 and CD38xCD3 Bispecific Antibodies, at the 2018 ASCO Annual Meeting

Glenmark Pharmaceuticals, a global pharmaceutical company, today announced the presentation of data from two assets in its immuno-oncology portfolio at the 2018 Annual Meeting of the American Society of Clinical Oncology (ASCO).

May 25, 2018
·
4 min read